Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization.
Neutralizing antibodies (NAbs) to multiple epitopes on the HIV-1-envelope glycoprotein (Env) have been isolated from infected persons. The potency of NAbs is measured more often than the size of the persistent fraction of infectivity at maximum neutralization, which may also influence preventive eff...
Saved in:
| Main Authors: | Rajesh P Ringe, Philippe Colin, Gabriel Ozorowski, Joel D Allen, Anila Yasmeen, Gemma E Seabright, Jeong Hyun Lee, Aleksandar Antanasijevic, Kimmo Rantalainen, Thomas Ketas, John P Moore, Andrew B Ward, Max Crispin, P J Klasse |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-10-01
|
| Series: | PLoS Pathogens |
| Online Access: | https://doi.org/10.1371/journal.ppat.1011601 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A cross-neutralizing antibody between HIV-1 and influenza virus.
by: Chang-Chun D Lee, et al.
Published: (2021-03-01) -
Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.
by: Rami Sommerstein, et al.
Published: (2015-11-01) -
Enhanced variant neutralization through glycan masking of SARS-CoV-2 XBB1.5 RBD
by: Joey Olivier, et al.
Published: (2025-12-01) -
HIV-1 neutralization profile and plant-based recombinant expression of actinohivin, an Env glycan-specific lectin devoid of T-cell mitogenic activity.
by: Nobuyuki Matoba, et al.
Published: (2010-06-01) -
Poly-β-D-(1,6)-N-acetyl-glucosamine (PNAG) glycan vaccines with broad spectrum neutralizing activities
by: Kuo-Shiang Liao, et al.
Published: (2025-07-01)